Abiraterone is a potent, selective, and irreversible inhibitor of cytochrome P-450c17 (CYP17A1), a key enzyme in the steroidogenesis pathway that plays a crucial role in the adrenal glands, testes, and prostate cancer cells [2]. The gene discussed is CYP17A1; the disease is prostate carcinoma.